Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
1.135
-0.025 (-2.12%)
May 14, 2025, 10:14 AM - Market open
Tevogen Bio Holdings Employees
Tevogen Bio Holdings had 18 employees as of December 31, 2024.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$570,761
Market Cap
208.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TVGN News
- 2 days ago - Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - GlobeNewsWire
- 11 days ago - Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest - GlobeNewsWire
- 13 days ago - CD8 Technology Signs Letter of Intent for Tevogen Bio's In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment - GlobeNewsWire
- 14 days ago - Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts - GlobeNewsWire
- 15 days ago - Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ's Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald - GlobeNewsWire
- 15 days ago - Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion - GlobeNewsWire
- 18 days ago - Tevogen Bio Announces 2025 Annual Meeting - GlobeNewsWire
- 26 days ago - Tevogen Bio Finalizes Agreement for Company's Own Cell Therapy Production Facility - GlobeNewsWire